Shattuck Labs Inc. share price logo

Shattuck Labs Inc. Share Price

NASDAQ: STTK

Small Cap

$1.82

-0.10

(-5.21%)

as on

Shattuck Labs Inc. Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $1.76
    $1.96
    downward going graph

    3.30%

    Downside

    7.69%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.69
    $3.95
    downward going graph

    61.97%

    Downside

    117.03%

    Upside

    downward going graph

Shattuck Labs Inc. share price movements today

Previous Close
$1.92
Open
$1.96
Volume
849.0K
Day's Low - High
$1.76 - $1.96
52 Week Low - High
$0.69 - $3.95

Shattuck Labs Inc. Historical Returns

1 Month Return
+ 92 %
3 Month Return
+ 90.1 %
1 Year Return
-49.61 %
3 Year Return
-41.64 %
5 Year Return
0 %

Shattuck Labs Inc. Stock Fundamentals & Key Indicators

Check Shattuck Labs Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$92.0M

EPS (TTM)

-0.788

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.95

Industry PE ratio

-3.8535542168674697

P/B Ratio

0

PEG Ratio

0

EBITDA

-61.0M

Revenue (TTM)

3.0M

Profit Margin

0.00%

Return On Equity TTM

0.00%

Shattuck Labs Inc. Stock Valuation

Track how Shattuck Labs Inc. P/E has moved over time to understand its valuation trends.

Shattuck Labs Inc. in the last 5 years

  • Overview

  • Trends

Lowest (0.00x)

September 15, 2025

Industry (-3.85x)

September 15, 2025

Today (-1.95x)

September 15, 2025

Highest (-0.83x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: -1.95x

Shattuck Labs Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Shattuck Labs Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Shattuck Labs Inc. image
Shattuck Labs Inc.
BUY$92.0MNA-1.950.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.1B256.98%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$38.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$101.1B47.85%28.0731.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Shattuck Labs Inc. Stock including INR - Dollar returns

The Shattuck Labs Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Shattuck Labs Inc. investment value today

Current value as on today

₹52,754

Returns

₹47,246

(-47.25%)

Returns from Shattuck Labs Inc. Stock

₹52,231 (-52.23%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Shattuck Labs Inc. Stock

Based on 12 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Shattuck Labs Inc.. Average target price of $2.31

Shattuck Labs Inc. Share Price Target

Get share price movements and forecasts by analysts on Shattuck Labs Inc..

What analysts predicted

21.21%UPSIDE

Target Price

$2.31

Current Price

$1.82

Analyzed by

12 Analysts

Target

$2.31

Shattuck Labs Inc. target price $2.31, a slight upside of 21.21% compared to current price of $1.82. According to 12 analysts rating.

Shattuck Labs Inc. Stock's Interest Amongst Investors

Search interest for Shattuck Labs Inc. Stock has increased by 44% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:44% versus previous 30 day period

Shattuck Labs Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
0
0
0
0
1
1
2
34
14
-
Gross Profit
-1
0
0
0
0
0
2
14
0
0
Operating Income
-21
-22
-28
-18
-20
-22
-17
-19
-14
-13
EBITDA
-20
-21
-27
-17
-19
-22
-16
-18
-13
-13
Interest Expense
0
-
-
0
-
-
-
-
-
-
Depreciation
1
1
1
0
0
0
0
0
0
0
Income Before Tax
-20
-21
-27
-17
-18
-21
-16
-18
-13
-12
Income Tax Expense
0
0
1
0
0
-
-
-
-
-
Net Income
-20
-21
-27
-17
-18
-21
-16
-18
-13
-12
Net Profit Margin
-36357.89%
-10673.00%
-4014.72%
-2477.17%
-1659.55%
-1339.47%
-556.39%
-53.82%
-94.55%
0.00%

Shattuck Labs Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
22
9
9
30
0
1
5
Gross Profit
-2
-19
9
28
0
-2
1
Operating Income
-6
-25
-36
-45
-103
-91
-80
EBITDA
-4
-24
-36
-43
-100
-87
-76
Interest Expense
2
-
-
1
3
-
-
Depreciation
0
0
0
1
3
4
3
Income Before Tax
-7
-23
-36
-44
-101
-87
-75
Income Tax Expense
1
0
-1
0
-1
3
-
Net Income
-7
-23
-35
-44
-100
-87
-75
Net Profit Margin
-32.92%
-241.56%
-356.71%
-149.83%
-15423.47%
-5268.44%
-1318.13%

Shattuck Labs Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-21
-27
-17
-18
-21
-16
-18
-13
-12
Operating Cash Flow
-18
-16
-19
-16
-10
-16
-17
-12
-10
Investing Cash Flow
24
-14
55
-33
-5
0
31
15
-
Financing Cash Flow
0
0
48
0
1
0
0
0
-
Change in Cash
5
-31
84
-49
-15
-16
13
3
-10

Shattuck Labs Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-23
-36
-44
-101
-87
-75
Operating Cash Flow
-20
-33
-57
-94
-81
-60
Investing Cash Flow
-3
-146
-10
49
110
-8
Financing Cash Flow
0
330
1
0
48
0
Change in Cash
-24
150
-65
-44
78
-68

Global Institutional Holdings in Shattuck Labs Inc.

Funds
Holdings
Prosight Management, LP
13.86%
Redmile Group, LLC
11.56%
Adage Capital Partners Gp LLC
9.76%
BlackRock Inc
5.44%
Vanguard Group Inc
5.01%
See all

Insights on Shattuck Labs Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, STTK stock has moved up by 92.0%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -18.67M → -12.45M (in $), with an average increase of 23.2% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 125.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 165.1%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 34.70M → 14.49M (in $), with an average decrease of 58.2% per quarter

About Shattuck Labs Inc.

shattuck is a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. compounds derived from shattuck’s proprietary agonist redirected checkpoint, arc®, platform simultaneously inhibit checkpoint molecules and activate costimulatory molecules within a single therapeutic. the company’s lead wholly owned program, sl-172154 (sirpα-fc-cd40l), which is designed to block the cd47 immune checkpoint and simultaneously agonize the cd40 pathway, is being evaluated in a phase 1 trial. a second compound, sl-279252 (pd1-fc-ox40l), is being evaluated in a phase 1 trial in collaboration with takeda pharmaceuticals. additionally, the company is advancing a proprietary gamma delta t cell engager, gadlen™, platform, which is designed to bridge gamma delta t cells to tumor antigens for the treatment of patients with cancer. shattuck has offices in both austin, tex
OrganisationShattuck Labs Inc.
Headquarters500 West 5th Street, Austin, TX, United States, 78701
IndustryHealth Technology
CEODr. Taylor H. Schreiber M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Shattuck Labs Inc.

Name

Title

Dr. Taylor H. Schreiber M.D., Ph.D.

Co-Founder, CEO & Director

Mr. Conor Richardson CPA

Vice President of Investor Relations

Ms. Casi DeYoung

Chief Business Officer

Dr. Thomas Lampkin Pharm.D.

Senior Vice President of Regulatory Affairs

Mr. George Fromm Ph.D.

Co-Chief Scientific Officer

Mr. Andrew R. Neill M.B.A.

Chief Financial Officer

Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.

Chief Medical Officer

Dr. Abhinav A. Shukla Ph.D.

Chief Technical Officer

Dr. Stephen Stout J.D., Ph.D.

General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer

Mr. Suresh de Silva Ph.D.

Co-Chief Scientific Officer

FAQs

What is Shattuck Labs Inc. share price today?

Shattuck Labs Inc. share price today is $1.82 as on at the close of the market. Shattuck Labs Inc. share today touched a day high of $1.96 and a low of $1.76.

What is the 52 week high and 52 week low for Shattuck Labs Inc. share?

Shattuck Labs Inc. share touched a 52 week high of $3.95 on and a 52 week low of $0.69 on . Shattuck Labs Inc. stock price today i.e. is closed at $1.82,which is 53.92% down from its 52 week high and 162.95% up from its 52 week low.

What is Shattuck Labs Inc.'s market capitalisation today?

Shattuck Labs Inc. market capitalisation is $0.00T as on .

How to invest in Shattuck Labs Inc. Stock (STTK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Shattuck Labs Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Shattuck Labs Inc. Shares that will get you 0.8242 shares as per Shattuck Labs Inc. share price of $1.82 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Shattuck Labs Inc. Stock (STTK) from India?

Indian investors can start investing in Shattuck Labs Inc. (STTK) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Shattuck Labs Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Shattuck Labs Inc. share’s latest price of $1.82 as on September 16, 2025 at 1:29 am IST, you will get 5.4945 shares of Shattuck Labs Inc.. Learn more about fractional shares .